🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

246,70 USD

Máx. histórico

246,70

0 días

Caída desde máximo

En máximo

Rango 52 semanas

80,91 – 255,19

Variación hoy

+5,86%

Cierre anterior

233,04

Rango de hoy

235,95 – 255,19

Volumen hoy

2.074.592

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,28%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 2 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/11/2025 92,00 97,79 91,84 96,49 +5,29% 6,47% 1.524.200
18/11/2025 88,20 92,49 87,32 91,64 +3,67% 5,86% 889.600
17/11/2025 89,51 92,60 88,28 88,40 -1,81% 4,83% 984.500
14/11/2025 90,65 93,14 88,76 90,03 -1,94% 4,84% 1.131.100
13/11/2025 91,17 97,22 91,17 91,81 -0,86% 6,64% 2.607.500
12/11/2025 90,87 93,00 88,60 92,61 +3,03% 4,84% 1.679.700
11/11/2025 88,82 92,14 88,72 89,89 +1,74% 3,85% 1.530.400
10/11/2025 83,78 88,61 83,78 88,35 +5,35% 5,77% 1.140.700
07/11/2025 81,80 84,36 80,91 83,86 +2,53% 4,22% 988.300
06/11/2025 83,95 84,08 81,61 81,79 -3,03% 2,94% 597.400
05/11/2025 85,25 86,82 83,36 84,35 -1,86% 4,06% 691.800
04/11/2025 85,86 88,29 85,16 85,95 -1,65% 3,65% 767.500
03/11/2025 88,09 88,67 83,46 87,39 -0,77% 5,91% 1.373.900
31/10/2025 86,53 90,62 85,86 88,07 +0,31% 5,49% 1.634.400
30/10/2025 95,07 102,80 85,85 87,80 +13,89% 17,83% 4.834.300
29/10/2025 77,07 81,00 76,88 77,09 -0,90% 5,35% 2.372.100
28/10/2025 75,00 77,83 73,16 77,79 +2,79% 6,23% 1.468.400
27/10/2025 79,50 79,50 74,51 75,68 +1,35% 6,28% 2.699.400
24/10/2025 75,80 76,08 74,55 74,67 -0,78% 2,02% 1.309.100
23/10/2025 76,21 77,07 75,01 75,26 -1,79% 2,70% 883.900
22/10/2025 76,99 76,99 74,44 76,63 +0,99% 3,31% 1.689.700
21/10/2025 79,51 79,73 73,73 75,88 -4,52% 7,55% 3.138.700
20/10/2025 88,80 89,75 75,36 79,47 -8,83% 16,20% 3.190.300
17/10/2025 84,79 88,94 84,79 87,17 +2,16% 4,89% 707.700
16/10/2025 85,89 87,48 84,54 85,33 -0,32% 3,42% 749.300
15/10/2025 85,74 86,37 83,35 85,60 +0,33% 3,52% 753.700
14/10/2025 83,22 86,74 82,46 85,32 +2,68% 5,14% 1.121.000
13/10/2025 83,58 84,70 82,19 83,09 +0,64% 3,00% 719.100
10/10/2025 87,00 87,00 82,37 82,56 -5,13% 5,32% 703.700
09/10/2025 87,59 87,83 86,18 87,02 -0,65% 1,89% 354.200